News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
687,907 Results
Type
Article (39148)
Company Profile (283)
Press Release (648476)
Section
Business (203904)
Career Advice (1996)
Deals (35373)
Drug Delivery (90)
Drug Development (80850)
Employer Resources (168)
FDA (16098)
Job Trends (14808)
News (344645)
Policy (32450)
Tag
Academia (2530)
Alliances (49183)
Alzheimer's disease (1257)
Approvals (16049)
Artificial intelligence (144)
Bankruptcy (352)
Best Places to Work (11581)
Biotechnology (200)
Breast cancer (188)
Cancer (1365)
Cardiovascular disease (110)
Career advice (1664)
Cell therapy (282)
Clinical research (64693)
Collaboration (482)
Compensation (260)
COVID-19 (2541)
C-suite (108)
Data (1389)
Diabetes (172)
Diagnostics (6170)
Earnings (84892)
Employer resources (146)
Events (110006)
Executive appointments (394)
FDA (16767)
Funding (426)
Gene therapy (195)
GLP-1 (597)
Government (4333)
Healthcare (18693)
Infectious disease (2633)
Inflammatory bowel disease (111)
Interviews (309)
IPO (16341)
Job creations (3625)
Job search strategy (1418)
Layoffs (418)
Legal (7861)
Lung cancer (197)
Lymphoma (98)
Manufacturing (207)
Medical device (13212)
Medtech (13217)
Mergers & acquisitions (19192)
Metabolic disorders (452)
Neuroscience (1577)
NextGen Class of 2024 (6500)
Non-profit (4467)
Northern California (1693)
Obesity (258)
Opinion (183)
Patents (117)
People (56459)
Phase I (20120)
Phase II (28494)
Phase III (21237)
Pipeline (514)
Postmarket research (2560)
Preclinical (8546)
Radiopharmaceuticals (236)
Rare diseases (259)
Real estate (5890)
Regulatory (21664)
Research institute (2310)
Resumes & cover letters (349)
Southern California (1460)
Startups (3562)
United States (15141)
Vaccines (563)
Weight loss (181)
Date
Today (33)
Last 7 days (580)
Last 30 days (2415)
Last 365 days (35205)
2024 (35003)
2023 (40079)
2022 (51174)
2021 (55711)
2020 (54086)
2019 (46542)
2018 (35019)
2017 (32110)
2016 (31480)
2015 (37553)
2014 (31318)
2013 (26345)
2012 (28571)
2011 (29263)
2010 (27329)
Location
Africa (713)
Arizona (195)
Asia (37266)
Australia (6087)
California (3809)
Canada (1449)
China (304)
Colorado (171)
Connecticut (176)
Europe (79827)
Florida (533)
Georgia (135)
Illinois (384)
Indiana (224)
Maryland (626)
Massachusetts (2959)
Michigan (172)
Minnesota (290)
New Jersey (1100)
New York (1080)
North Carolina (742)
Northern California (1693)
Ohio (146)
Pennsylvania (923)
South America (1091)
Southern California (1460)
Texas (547)
Utah (108)
Washington State (399)
687,907 Results for "lyell immunopharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lyell Immunopharma Completes Acquisition of ImmPACT Bio
October 31, 2024
·
6 min read
Biotech Bay
Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference - June 3, 2024
Lyell Immunopharma, Inc today announced that members of its senior management team will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on Monday, June 10 at 4:00 pm ET.
June 3, 2024
·
1 min read
Biotech Bay
Lyell Immunopharma to Participate in BofA Securities Health Care Conference 2024
Lyell Immunopharma, Inc. announced that members of its senior management team will participate in the BofA Securities 2024 Health Care Conference on Tuesday, May 14 at 8:40 am PT.
May 7, 2024
·
1 min read
Press Releases
Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2024
November 8, 2024
·
15 min read
Business
Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2024
Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with solid tumors today reported financial results and business highlights for the first quarter ended March 31, 2024.
May 6, 2024
·
13 min read
Business
Lyell Immunopharma Announces Participation in Goldman Sachs Cell Therapy Day
September 24, 2024
·
1 min read
Business
Lyell Immunopharma Announces Participation in September Investor Conferences
August 28, 2024
·
1 min read
Drug Development
Lyell Immunopharma Reports Dose-dependent Clinical Activity from Phase 1 Trial of LYL797, a ROR1-targeted CAR-T Cell Product Candidate Enhanced with its Proprietary Anti-exhaustion Technology
Lyell Immunopharma, Inc. today announced initial clinical and translational data from its Phase 1 trial of LYL797, its first-generation reprogrammed ROR1 CAR T‑cell product candidate enhanced with proprietary anti-exhaustion technology.
June 26, 2024
·
13 min read
Biotech Bay
Lyell Immunopharma Announces Participation in March 2024 Investor Conferences
Lyell Immunopharma, Inc., a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with solid tumors, announced that members of its senior management team will present and participate the following upcoming investor conferences:
February 26, 2024
·
1 min read
Press Releases
Lyell Immunopharma to Acquire ImmPACT Bio and Prioritizes its Pipeline to Focus on Next-Generation CAR T-cell Therapies
October 25, 2024
·
11 min read
1 of 68,791
Next
